*ST Sailon: Announcement of Resolutions of the 18th Meeting of the Fourth Board of Directors

Securities code: 002898 Securities abbreviation: *ST Sailon Announcement number: 2025-092

Sailong Pharmaceutical Group Co., Ltd.

Announcement of Resolutions of the 18th Meeting of the Fourth Board of Directors

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.

1. Convening of board of directors meetings

The notice of the 18th meeting of the fourth board of directors of Sailong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") was delivered to all directors in writing on November 22, 2025, by a combination of personal delivery, fax, email, and instant messaging. The meeting was held on November 24, 2025 in the company conference room on the 21st floor of Unit 2, No. 31 Nanwan North Road, Xiangzhou District, Zhuhai City, through a combination of on-site and communication methods. 9 directors were supposed to attend the meeting, and 9 directors actually attended. The meeting was chaired by Mr. Yin Huijun, chairman of the company, and the company's senior managers attended the meeting. The convening, holding and voting of this meeting complied with the provisions of relevant laws, administrative regulations, other normative documents and the Articles of Association.

2. Review status of board of directors meeting

1. Reviewed and approved the "Proposal on Changing the Company's Business Scope and Amending the Company's Articles of Association"

For details, please refer to the "Announcement on Changing the Company's Business Scope and Revising the Articles of Association" published on the cninfo.com (www.cninfo.com.cn) on the same day (announcement number: 2025-093).

Voting results: 9 votes, 9 in favor, 0 against, and 0 abstentions.

This proposal still needs to be submitted to the company's shareholders' meeting for review and approval.

2. Reviewed and approved the "Proposal on Subsidiaries' Application for Comprehensive Credit Lines from Banks and Provision of Guarantees"

For details, please refer to the "Announcement on Subsidiaries' Application for Comprehensive Credit Lines from Banks and Provision of Guarantees" (Announcement No.: 2025-094) published on the cninfo.com (www.cninfo.com.cn) on the same day. Voting results: 9 votes, 9 in favor, 0 against, and 0 abstentions.

This proposal still needs to be submitted to the company's shareholders' meeting for review and approval.

3. Reviewed and approved the “Proposal on Convening the Fourth Extraordinary Shareholders’ Meeting in 2025”

For details, please refer to the "Notice on Convening the Fourth Extraordinary Shareholders Meeting in 2025" published on the cninfo.com (www.cninfo.com.cn) on the same day (announcement number: 2025-095).

Voting results: 9 votes, 9 in favor, 0 against, and 0 abstentions.

3. Documents for reference

1. Resolution of the 18th meeting of the fourth board of directors;

2. Review opinions of the third special meeting of the independent directors of the fourth board of directors in 2025.

Announcement is hereby made.

The Board of Directors of Sailon Pharmaceutical Group Co., Ltd.

November 25, 2025